Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems.
This report elaborates on the current development of the Multiple Sclerosis Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
ACORDA
Mallinckrodt
Biogen
Bayer
Merck KGaA
Teva
Sanofi
By Type:
Oral medications
Infused medications
Injectable medications
By Application:
Relapsing forms of MS
Improve walking in patients with MS
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Multiple Sclerosis Drugs Market Overview 2018-2029
-
1.1 China Multiple Sclerosis Drugs Industry Development Overview
-
1.2 China Multiple Sclerosis Drugs Industry Development History
-
1.3 China Multiple Sclerosis Drugs Industry Market Size (2018-2029)
-
1.4 China Multiple Sclerosis Drugs Market Analysis by Type from Production Side
-
1.4.1 China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Oral medications (2018-2029)
-
1.4.2 China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Infused medications (2018-2029)
-
1.4.3 China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Injectable medications (2018-2029)
-
1.5 China Multiple Sclerosis Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Multiple Sclerosis Drugs Sales Volume, Sales Value and Growth Rate of Relapsing forms of MS (2018-2029)
-
1.5.2 China Multiple Sclerosis Drugs Sales Volume, Sales Value and Growth Rate of Improve walking in patients with MS (2018-2029)
-
1.6 China Multiple Sclerosis Drugs Market Analysis by Region
-
1.6.1 North China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Multiple Sclerosis Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Multiple Sclerosis Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Multiple Sclerosis Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Multiple Sclerosis Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Multiple Sclerosis Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Multiple Sclerosis Drugs Industry Development
Chapter 3 Multiple Sclerosis DrugsIndustry Chain Analysis
-
3.1 Multiple Sclerosis Drugs Industry Chain
-
3.2 Multiple Sclerosis Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Multiple Sclerosis Drugs Market
-
3.3 Multiple Sclerosis Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Multiple Sclerosis Drugs Market
Chapter 4 China Multiple Sclerosis Drugs Market, by Type
-
4.1 China Multiple Sclerosis Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Multiple Sclerosis Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Multiple Sclerosis Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Multiple Sclerosis Drugs Production Volume and Growth Rate of Oral medications
-
4.5.2 China Multiple Sclerosis Drugs Production Volume and Growth Rate of Infused medications
-
4.5.3 China Multiple Sclerosis Drugs Production Volume and Growth Rate of Injectable medications
Chapter 5 China Multiple Sclerosis Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Multiple Sclerosis Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Multiple Sclerosis Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Multiple Sclerosis Drugs Market Size and Growth Rate of Relapsing forms of MS
-
5.5.2 China Multiple Sclerosis Drugs Market Size and Growth Rate of Improve walking in patients with MS
Chapter 6 China Multiple Sclerosis Drugs Market, by Region
-
6.1 China Multiple Sclerosis Drugs Production Volume and Production Value, by Region
-
6.2 China Multiple Sclerosis Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Multiple Sclerosis Drugs Market Analysis
-
7.1 North China Multiple Sclerosis Drugs Market, by Type
-
7.2 North China Multiple Sclerosis Drugs Market, by Application
Chapter 8 Central China Multiple Sclerosis Drugs Market Analysis
-
8.1 Central China Multiple Sclerosis Drugs Market, by Type
-
8.2 Central China Multiple Sclerosis Drugs Market, by Application
Chapter 9 South China Multiple Sclerosis Drugs Market Analysis
-
9.1 South China Multiple Sclerosis Drugs Market, by Type
-
9.2 South China Multiple Sclerosis Drugs Market, by Application
Chapter 10 East China Multiple Sclerosis Drugs Market Analysis
-
10.1 East China Multiple Sclerosis Drugs Market, by Type
-
10.2 East China Multiple Sclerosis Drugs Market, by Application
Chapter 11 Northeast China Multiple Sclerosis Drugs Market Analysis
-
11.1 Northeast China Multiple Sclerosis Drugs Market, by Type
-
11.2 Northeast China Multiple Sclerosis Drugs Market, by Application
Chapter 12 Southwest China Multiple Sclerosis Drugs Market Analysis
-
12.1 Southwest China Multiple Sclerosis Drugs Market, by Type
-
12.2 Southwest China Multiple Sclerosis Drugs Market, by Application
Chapter 13 Northwest China Multiple Sclerosis Drugs Market Analysis
-
13.1 Northwest China Multiple Sclerosis Drugs Market, by Type
-
13.2 Northwest China Multiple Sclerosis Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 ACORDA
-
14.1.1 ACORDA Company Profile
-
14.1.2 ACORDA Multiple Sclerosis Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Mallinckrodt
-
14.2.1 Mallinckrodt Company Profile
-
14.2.2 Mallinckrodt Multiple Sclerosis Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Biogen
-
14.3.1 Biogen Company Profile
-
14.3.2 Biogen Multiple Sclerosis Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bayer
-
14.4.1 Bayer Company Profile
-
14.4.2 Bayer Multiple Sclerosis Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Merck KGaA
-
14.5.1 Merck KGaA Company Profile
-
14.5.2 Merck KGaA Multiple Sclerosis Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Teva
-
14.6.1 Teva Company Profile
-
14.6.2 Teva Multiple Sclerosis Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Sanofi
-
14.7.1 Sanofi Company Profile
-
14.7.2 Sanofi Multiple Sclerosis Drugs Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Multiple Sclerosis Drugs Industry Research Conclusions
-
15.2 Multiple Sclerosis Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Multiple Sclerosis Drugs Industry Market Size (2018-2029)
-
Figure China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Oral medications (2018-2029)
-
Figure China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Infused medications (2018-2029)
-
Figure China Multiple Sclerosis Drugs Production Volume, Production Value and Growth Rate of Injectable medications (2018-2029)
-
Figure China Multiple Sclerosis Drugs Sales Volume, Sales Value and Growth Rate of Relapsing forms of MS (2018-2029)
-
Figure China Multiple Sclerosis Drugs Sales Volume, Sales Value and Growth Rate of Improve walking in patients with MS (2018-2029)
-
Figure North China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Multiple Sclerosis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Multiple Sclerosis Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Multiple Sclerosis Drugs Market Share by Type in 2018
-
Figure China Multiple Sclerosis Drugs Market Share by Type in 2023
-
Figure China Multiple Sclerosis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Multiple Sclerosis Drugs Production Volume and Growth Rate of Oral medications (2018-2023)
-
Figure China Multiple Sclerosis Drugs Production Volume and Growth Rate of Infused medications (2018-2023)
-
Figure China Multiple Sclerosis Drugs Production Volume and Growth Rate of Injectable medications (2018-2023)
-
Figure China Multiple Sclerosis Drugs Market Share by Application in 2018
-
Figure China Multiple Sclerosis Drugs Market Share by Application in 2023
-
Figure China Multiple Sclerosis Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Multiple Sclerosis Drugs Market Size and Growth Rate of Relapsing forms of MS (2018-2023)
-
Figure China Multiple Sclerosis Drugs Market Size and Growth Rate of Improve walking in patients with MS (2018-2023)
-
Table China Multiple Sclerosis Drugs Production Volume by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Production Volume Share by Region (2018-2023)
-
Figure China Multiple Sclerosis Drugs Production Volume Share by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Production Value by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Production Value Share by Region (2018-2023)
-
Figure China Multiple Sclerosis Drugs Production Value Share by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Sales Volume by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Multiple Sclerosis Drugs Sales Volume Share by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Sales Value by Region (2018-2023)
-
Table China Multiple Sclerosis Drugs Sales Value Share by Region (2018-2023)
-
Figure China Multiple Sclerosis Drugs Sales Value Share by Region (2018-2023)
-
Table North China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table North China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table North China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table North China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table Central China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table Central China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table South China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table South China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table South China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table East China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table East China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table East China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Multiple Sclerosis Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Multiple Sclerosis Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Multiple Sclerosis Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Multiple Sclerosis Drugs Sales Volume Share by Application (2018-2023)
-
Table ACORDA Company Profile
-
Table ACORDA Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Mallinckrodt Company Profile
-
Table Mallinckrodt Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Biogen Company Profile
-
Table Biogen Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck KGaA Company Profile
-
Table Merck KGaA Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Teva Company Profile
-
Table Teva Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Multiple Sclerosis Drugs Revenue, Price and Gross (2018-2023)
-
